← Back to Search

Potassium Supplementation for Blood Pressure Control

N/A
Recruiting
Research Sponsored by University of Delaware
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up on day 10 of each diet
Awards & highlights

Study Summary

This trial tests if adding potassium to a high-sodium diet can help lower blood pressure & protect blood vessel & nervous system health.

Who is the study for?
This trial is for men and women aged 18-45, from any racial or ethnic background, who are in good cardiovascular health. Participants should have a body mass index (BMI) less than 30 and blood pressure below 130/80 mmHg.Check my eligibility
What is being tested?
The study is examining if taking potassium chloride supplements can help counteract the negative effects of a high-sodium diet on blood vessel function, blood pressure response, and the autonomic nervous system in healthy adults.See study design
What are the potential side effects?
Possible side effects of potassium chloride supplements may include stomach discomfort, diarrhea, nausea, vomiting or feelings of tingling in hands or feet.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~on day 10 of each diet
This trial's timeline: 3 weeks for screening, Varies for treatment, and on day 10 of each diet for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Blood pressure reactivity
Conduit artery endothelial dependent dilation
Superoxide levels

Trial Design

3Treatment groups
Experimental Treatment
Group I: Moderate potassium/low sodiumExperimental Treatment1 Intervention
Subjects will consume a diet moderation in potassium and low in sodium.
Group II: Moderate potassium/high sodiumExperimental Treatment1 Intervention
Subjects will consume a diet moderation in potassium and high in sodium.
Group III: High potassium/high sodiumExperimental Treatment1 Intervention
Subjects will consume a diet moderation in potassium and high in sodium.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Placebo
1995
Completed Phase 3
~2670

Find a Location

Who is running the clinical trial?

University of DelawareLead Sponsor
154 Previous Clinical Trials
25,059 Total Patients Enrolled
7 Trials studying Cardiovascular Risk
368 Patients Enrolled for Cardiovascular Risk

Media Library

Placebo Clinical Trial Eligibility Overview. Trial Name: NCT05887622 — N/A
Cardiovascular Risk Research Study Groups: Moderate potassium/low sodium, Moderate potassium/high sodium, High potassium/high sodium
Cardiovascular Risk Clinical Trial 2023: Placebo Highlights & Side Effects. Trial Name: NCT05887622 — N/A
Placebo 2023 Treatment Timeline for Medical Study. Trial Name: NCT05887622 — N/A
~6 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top